­

Press releases

2504, 2017

Bionaturis out-licenses its Leishmaniasis vaccine for Argentina and Paraguay

By |April 25th, 2017|Blog english, Press Releases|

Bionaturis has signed an exclusive development, manufacturing, registration, and commercialization license of its Leishmaniasis vaccine with the company Biotandil for Argentina and Paraguay
According to the terms of the license, Bionaturis will receive 50% of the profits resulting of the commercialization.
The immunization of these animals –the main reservoir of this neglected […]

1412, 2016

Bionaturis strengthens actions for reducing the use of antibiotics in the porcine industry

By |December 14th, 2016|Blog english, Press Releases|

The biotechnological company takes part in the PROVACIN consortium, joined by partners Piensos Jimenez –leaders of the project- and Iberico Comercializacion (IBERCOM), with the main goal of reducing the use of antibiotics in white and iberian pigs
The PROVACIN project acts on the whole value chain of livestock industry, by applying […]

305, 2016

Bionaturis Group grows through the acquisition of the company ZIP Solutions

By |May 3rd, 2016|Blog english, Press Releases|

Zera Intein Protein Solutions (ZIP) is specialized in the development of technologies for the production of peptides and recombinant proteins for both therapeutic and industrial interest, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors.
Both parties agreed as a mandatory irrevocably condition to trigger the transaction the event of […]

2501, 2016

Biobide signs a contract with the U.S. National Institute of Environmental Health Sciences (NIH-NIEHS)

By |January 25th, 2016|Blog english, Press Releases|

This project will analyze the toxicological impact of exposure to 30 chemical compounds using zebrafish as animal model.

The NIEHS is one of the 27 Institutes and Centers composing the US-National Institutes of Health.

January 25, 2016. BBD BioPhenix-Biobide (now part of Bionaturis Group), has recently signed a contract agreement with one […]

1201, 2016

Bionaturis Group takes part in the BIOMAP project

By |January 12th, 2016|Blog english, Press Releases|

BIOMAP is a consortium led by Laboratories Rovy  that includes Vivacell Biotechnology Spain, Vaxdyn,  and Bionaturis
The Feder-Interconecta Programme, via the Centre for the Development of Industrial Technology (CDTI, in Spanish), has granted Bionaturis 572.988€ for this biomedicine development initiative.

Jerez de la Frontera, January 12nd 2016. Bionaturis Group will take part […]

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR